mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |